MicroRNAs May Serve as Emerging Molecular Biomarkers for Diagnosis and Prognostic Assessment or as Targets for Therapy in Gastric Cancer |
Mu, Yong-Ping
(Department of Clinical Laboratory Center, The Affiliated People's Hospital of Inner Mongolia Medical University)
Sun, Wen-Jie (School of Public Health and Tropical Medicine, Tulane University) Lu, Chuan-Wen (Department of Environmental Toxicology, The Institute of Environmental and Human Health, Texas Tech University, Texas Tech University Health Sciences Center) Su, Xiu-Lan (Clinical Medicine Research Center, The Affiliated Hospital of Inner Mongolia Medical University) |
1 | Li L, Zhou L, Li Y, et al (2014a). MicroRNA-21 stimulates gastric cancer growth and invasion by inhibiting the tumor suppressor effects of programmed cell death protein 4 and phosphatase and tensin homolog. J buon, 19, 228-36. |
2 | Li LP, Wu WJ, Sun DY, et al (2014b). miR-449a and CDK6 in gastric carcinoma. Oncol Lett, 8, 1533-8. DOI |
3 | Li R, Yuan W, Mei W, et al (2014c). MicroRNA 520d-3p inhibits gastric cancer cell proliferation, migration, and invasion by downregulating EphA2 expression. Mol Cell Biochem, 396, 295-305. DOI |
4 | Li X, Wang F, Qi Y (2014d). MiR-126 inhibits the invasion of gastric cancer cell in part by targeting Crk. Eur Rev Med Pharmacol Sci, 18, 2031-7. |
5 | Liu D, Hu X, Zhou H, et al (2014a). Identification of Aberrantly Expressed miRNAs in Gastric Cancer. Gastroenterol Res Pract, 2014, 473817. |
6 | Liu LY, Wang W, Zhao LY, et al (2014b). Mir-126 inhibits growth of SGC-7901 cells by synergistically targeting the oncogenes PI3KR2 and Crk, and the tumor suppressor PLK2. Int J Oncol, 45, 1257-65. DOI |
7 | Ma GJ, Gu RM, Zhu M, et al (2013a). Plasma post-operative miR-21 expression in the prognosis of gastric cancers. Asian Pac J Cancer Prev, 14, 7551-4. DOI ScienceOn |
8 | Ma Y, Wang X, Jin H (2013b). Methylated DNA and microRNA in Body Fluids as Biomarkers for Cancer Detection. Int J Mol Sci, 14, 10307-31. DOI |
9 | Miao L, Liu K, Xie M, et al (2014). miR-375 inhibits Helicobacter pylori-induced gastric carcinogenesis by blocking JAK2-STAT3 signaling. Cancer Immunol Immunother, 63, 699-711. DOI |
10 | Mu YP, Su XL (2012). Polymorphism in pre-miR-30c contributes to gastric cancer risk in a Chinese population. Med Oncol, 29, 1723-32. DOI |
11 | Mu YP, Tang S, Sun WJ, et al (2014). Association of miR-193b Down-regulation and miR-196a up-Regulation with Clinicopathological Features and Prognosis in Gastric Cancer. Asian Pac J Cancer Prev, 15, 8893-900. DOI |
12 | Naito Y, Yasuno K, Tagawa H, et al (2014). MicroRNA-145 is a potential prognostic factor of scirrhous type gastric cancer. Oncol Rep, 32, 1720-6. DOI |
13 | Omura T, Shimada Y, Nagata T, et al (2014). Relapse-associated microRNA in gastric cancer patients after S-1 adjuvant chemotherapy. Oncol Rep, 31, 613-8. DOI |
14 | Seok JK, Lee SH, Kim MJ, et al (2014). MicroRNA-382 induced by HIF-1alpha is an angiogenic miR targeting the tumor suppressor phosphatase and tensin homolog. Nucleic Acids Res, 42, 8062-72. DOI |
15 | Shen J, Niu W, Zhou M, et al (2014a). MicroRNA-410 Suppresses Migration and Invasion by Targeting MDM2 in Gastric Cancer. PLoS One, 9, 104510. DOI |
16 | Shen Q, Yao Q, Sun J, et al (2014b). Downregulation of histone deacetylase 1 by microRNA-520h contributes to the chemotherapeutic effect of doxorubicin. FEBS Lett, 588, 184-91. DOI |
17 | Shin JY, Kim YI, Cho SJ, et al (2014). MicroRNA 135a suppresses lymph node metastasis through down-regulation of ROCK1 in early gastric cancer. PLoS One, 9, 85205. DOI |
18 | Song F, Yang D, Liu B, et al (2014). Integrated microRNA network analyses identify a poor-prognosis subtype of gastric cancer characterized by the miR-200 family. Clin Cancer Res, 20, 878-89. DOI |
19 | Song MY, Su HJ, Zhang L, et al (2013). Genetic polymorphisms of miR-146a and miR-27a, H. pylori infection, and risk of gastric lesions in a Chinese population. PLoS One, 8, 61250. DOI |
20 | Sun S, Sun P, Wang C, et al (2014). Downregulation of microRNA-155 accelerates cell growth and invasion by targeting c-myc in human gastric carcinoma cells. Oncol Rep, 32, 951-6. DOI |
21 | Sun Y, Zhang K, Fan G, et al (2012). Identification of circulating microRNAs as biomarkers in cancers: what have we got? Clin Chem Lab Med, 50, 2121-6. |
22 | Tahara T, Okubo M, Shibata T, et al (2014). Association Between Common Genetic Variants in Pre-MicroRNAs and Prognosis of Advanced Gastric Cancer Treated with Chemotherapy. Anticancer Res, 34, 5199-204. |
23 | Tan Z, Jiang H, Wu Y, et al (2014). miR-185 is an independent prognosis factor and suppresses tumor metastasis in gastric cancer. Mol Cell Biochem, 386, 223-31. DOI |
24 | Tian SB, Yu JC, Kang WM, et al (2014). [MicroRNA and gastric cancer]. Zhongguo Yi Xue Ke Xue Yuan Xue Bao, 36, 214-7. |
25 | Tsai MM, Wang CS, Tsai CY, et al (2014). MicroRNA-196a/-196b promote cell metastasis via negative regulation of radixin in human gastric cancer. Cancer Lett, 351, 222-31. DOI |
26 | Tsujiura M, Komatsu S, Ichikawa D, et al (2014). Circulating miR-18a in plasma contributes to cancer detection and monitoring in patients with gastric cancer. Gastric Cancer. |
27 | Tufekci KU, Meuwissen RL, Genc S (2014). The role of microRNAs in biological processes. Methods Mol Biol, 1107, 15-31. DOI |
28 | Wang T, Ge G, Ding Y, et al (2014a). MiR-503 regulates cisplatin resistance of human gastric cancer cell lines by targeting IGF1R and BCL2. Chin Med J (Engl), 127, 2357-62. |
29 | Wang W, Li F, Zhang Y, et al (2013). Reduced expression of miR-22 in gastric cancer is related to clinicopathologic characteristics or patient prognosis. Diagn Pathol, 8, 102. DOI |
30 | Wang Z, Cai Q, Jiang Z, et al (2014b). Prognostic Role of MicroRNA-21 in Gastric Cancer: a Meta-Analysis. Med Sci Monit, 20, 1668-74. DOI |
31 | Wu CW, Hsiung CA, Lo SS, et al (2006). Nodal dissection for patients with gastric cancer: a randomised controlled trial. Lancet Oncol, 7, 309-15. DOI |
32 | Wu JH, Yao YL, Gu T, et al (2014). MiR-421 regulates apoptosis of BGC-823 gastric cancer cells by targeting caspase-3. Asian Pac J Cancer Prev, 15, 5463-8. DOI ScienceOn |
33 | Xia JT, Chen LZ, Jian WH, et al (2014). MicroRNA-362 induces cell proliferation and apoptosis resistance in gastric cancer by activation of NF-kappaB signaling. J Transl Med, 12, 33. DOI |
34 | Xu Q, Dong Q, He C, et al (2014a). A new polymorphism biomarker rs629367 associated with increased risk and poor survival of gastric cancer in chinese by up-regulated miRNA-let-7a expression. PLoS One, 9, 95249. DOI |
35 | Xu Y, Huang Z, Liu Y (2014b). Reduced miR-125a-5p expression is associated with gastric carcinogenesis through the targeting of E2F3. Mol Med Rep, 10, 2601-8. DOI |
36 | Xu Y, Jin J, Liu Y, et al (2014c). Snail-regulated MiR-375 inhibits migration and invasion of gastric cancer cells by targeting JAK2. PLoS One, 9, 99516. DOI |
37 | Xu YJ, Fan Y (2014). MiR-215/192 participates in gastric cancer progression. Clin Transl Oncol, 17, 34-40. |
38 | Yan W, Wang S, Sun Z, et al (2014). Identification of microRNAs as potential biomarker for gastric cancer by system biological analysis. Biomed Res Int, 2014, 901428. |
39 | Yang M, Shan X, Zhou X, et al (2014a). miR-1271 regulates cisplatin resistance of human gastric cancer cell lines by targeting IGF1R, IRS1, mTOR, and BCL2. Anticancer Agents Med Chem, 14, 884-91. DOI |
40 | Yang O, Huang J, Lin S (2014b). Regulatory effects of miRNA on gastric cancer cells. Oncol Lett, 8, 651-6. DOI |
41 | Yang Q, Jie Z, Ye S, et al (2014c). Genetic variations in miR-27a gene decrease mature miR-27a level and reduce gastric cancer susceptibility. Oncogene, 33, 193-202. DOI |
42 | Yang Q, Zhang C, Huang B, et al (2013). Downregulation of microRNA-206 is a potent prognostic marker for patients with gastric cancer. Eur J Gastroenterol Hepatol, 25, 953-7. DOI |
43 | Zhang R, Wang W, Li F, et al (2014a). MicroRNA-106b-25 expressions in tumor tissues and plasma of patients with gastric cancers. Med Oncol, 31, 243. DOI |
44 | Zhang XL, Shi HJ, Wang JP, et al (2014b). MicroRNA-218 is upregulated in gastric cancer after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy and increases chemosensitivity to cisplatin. World J Gastroenterol, 20, 11347-55. DOI |
45 | Zheng G, Xiong Y, Xu W, et al (2014). A two-microRNA signature as a potential biomarker for early gastric cancer. Oncol Lett, 7, 679-84. DOI |
46 | Zheng L, Pu J, Qi T, et al (2013). miRNA-145 targets v-ets erythroblastosis virus E26 oncogene homolog 1 to suppress the invasion, metastasis, and angiogenesis of gastric cancer cells. Mol Cancer Res, 11, 182-93. DOI |
47 | Zhou X, Li L, Su J, et al (2014). Decreased miR-204 in H. pylori-associated gastric cancer promotes cancer cell proliferation and invasion by targeting SOX4. Scientifica (Cairo), 9, 101457. |
48 | Zhu ED, Li N, Li BS, et al (2014a). miR-30b, Down-Regulated in Gastric Cancer, Promotes Apoptosis and Suppresses Tumor Growth by Targeting Plasminogen Activator Inhibitor-1. PLoS One, 9, 106049. DOI |
49 | Chang L, Guo F, Wang Y, et al (2014). MicroRNA-200c regulates the sensitivity of chemotherapy of gastric cancer SGC7901/DDP cells by directly targeting RhoE. Pathol Oncol Res, 20, 93-8. DOI |
50 | Zhu M, Zhang N, He S (2014b). Similarly up-regulated microRNA-106a in matched formalin-fixed paraffin-embedded and fresh frozen samples and the dynamic changes during gastric carcinogenesis and development. Pathol Res Pract, 210, 909-15. DOI |
51 | Chen L, Lu MH, Zhang D, et al (2014a). miR-1207-5p and miR-1266 suppress gastric cancer growth and invasion by targeting telomerase reverse transcriptase. Cell Death Dis, 5, 1034. DOI |
52 | Chen Q, Ge X, Zhang Y, et al (2014b). Plasma miR-122 and miR-192 as potential novel biomarkers for the early detection of distant metastasis of gastric cancer. Oncol Rep, 31, 1863-70. DOI |
53 | Chen X, Ba Y, Ma L, et al (2008). Characterization of microRNAs in serum: a novel class of biomarkers for diagnosis of cancer and other diseases. Cell Res, 18, 997-1006. DOI |
54 | Duan Y, Hu L, Liu B, et al (2014). Tumor suppressor miR-24 restrains gastric cancer progression by downregulating RegIV. Mol Cancer, 13, 127. DOI |
55 | Crew KD, Neugut AI (2006). Epidemiology of gastric cancer. World J Gastroenterol, 12, 354-62. DOI |
56 | Du Y, Wang D, Luo L, et al (2014). miR-129-1-3p Promote BGC-823 Cell Proliferation by Targeting PDCD2. Anat Rec (Hoboken), 297, 2273-9. DOI |
57 | Duan JH, Fang L (2014). MicroRNA-92 promotes gastric cancer cell proliferation and invasion through targeting FXR. Tumour Biol, 35, 11013-9. DOI |
58 | Ekimler S, Sahin K (2014). Computational Methods for MicroRNA Target Prediction. Genes (Basel), 5, 671-83. DOI |
59 | El-Zimaity HM, Ota H, Graham DY, et al (2002). Patterns of gastric atrophy in intestinal type gastric carcinoma. Cancer, 94, 1428-36. DOI |
60 | Fesler A, Zhai H, Ju J (2014). miR-129 as a novel therapeutic target and biomarker in gastrointestinal cancer. Onco Targets Ther, 7, 1481-5. |
61 | Fu Z, Qian F, Yang X, et al (2014). Circulating miR-222 in plasma and its potential diagnostic and prognostic value in gastric cancer. Med Oncol, 31, 164. DOI |
62 | Guo B, Li J, Liu L, et al (2013). Dysregulation of miRNAs and their potential as biomarkers for the diagnosis of gastric cancer. Biomed Rep, 1, 907-12. DOI |
63 | Han TS, Hur K (2015). MicroRNA-29c mediates initiation of gastric carcinogenesis by directly targeting ITGB1.Gut, 64, 203-14. DOI |
64 | Hayes J, Peruzzi PP, Lawler S (2014). MicroRNAs in cancer: biomarkers, functions and therapy. Trends Mol Med, 20, 460-9. DOI |
65 | Jemal A, Bray F, Center MM, et al (2011). Global cancer statistics. CA Cancer J Clin, 61, 69-90. DOI |
66 | Hibino S, Saito Y, Muramatsu T, et al (2014). Inhibitors of enhancer of zeste homolog 2 (EZH2) activate tumor-suppressor microRNAs in human cancer cells. Oncogenesis, 3, 104. DOI |
67 | Hu CB, Li QL, Hu JF, et al (2014a). miR-124 Inhibits Growth and Invasion of Gastric Cancer by Targeting ROCK1. Asian Pac J Cancer Prev, 15, 6543-6. DOI |
68 | Hu Q, Peng J, Liu W, et al (2014b). Lin28B is a novel prognostic marker in gastric adenocarcinoma. Int J Clin Exp Pathol, 7, 5083-92. |
69 | Keller A, Leidinger P, Gislefoss R, et al (2011). Stable serum miRNA profiles as potential tool for non-invasive lung cancer diagnosis. RNA Biol, 8, 506-16. DOI |
70 | Kiga K, Mimuro H, Suzuki M, et al (2014). Epigenetic silencing of miR-210 increases the proliferation of gastric epithelium during chronic Helicobacter pylori infection. Nat Commun, 5, 4497. DOI |
71 | Komatsu S, Ichikawa D, Tsujiura M, et al (2013). Prognostic impact of circulating miR-21 in the plasma of patients with gastric carcinoma. Anticancer Res, 33, 271-6. |
72 | Lasser C (2013). Identification and analysis of circulating exosomal microRNA in human body fluids. Methods Mol Biol, 1024, 109-28. DOI |
73 | Lee Y, Ahn C, Han J, et al (2003). The nuclear RNase III Drosha initiates microRNA processing. Nature, 425, 415-9. DOI |
74 | Li L, Sheng Y, Lv L, et al (2013). The association between two microRNA variants (miR-499, miR-149) and gastrointestinal cancer risk: a meta-analysis. PLoS One, 8, 81967. DOI |